Myriad(MYGN) - 2024 Q1 - Earnings Call Transcript

Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2024 Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants Matthew Scalo - Senior Vice President of Investor Relations Paul Diaz - President and Chief Executive Officer Mark Verratti - Chief Commercial Officer Sam Raha - Chief Operating Officer Scott Leffler - Chief Financial Officer Conference Call Participants Matthew Sykes - Goldman Sachs Doug Schenkel - Wolfe Research, LLC Daniel Brennan - TD Cowen Puneet Souda - Leerink Partners LLC Andrew Cooper - ...